The disposition and metabolism of 2-amino-3-methylimidazo[4,5-f]quinoline in the F344 rat at high versus low doses of indole-3-carbinol

被引:9
作者
Dashwood, RH [1 ]
Xu, M
机构
[1] Oregon State Univ, Linus Pauling Inst, Corvallis, OR 97331 USA
[2] Oregon State Univ, Dept Environm & Mol Toxicol, Corvallis, OR 97331 USA
关键词
heterocyclic amines; antimutagenesis; chemoprevention; cruciferous vegetables; IQ; phytoestrogens; breast cancer; colonic aberrant crypts;
D O I
10.1016/S0278-6915(03)00110-8
中图分类号
TS2 [食品工业];
学科分类号
0832 [食品科学与工程];
摘要
Indole-3-carbinol (I3C), a compound found in cruciferous vegetables, inhibits the formation of DNA adducts, colonic aberrant crypts, and tumors in rats given heterocyclic amines, such as 2-amino-3-methylimidazo[4,5-f]quinoline (IQ). Previous mechanism studies indicated that I3C induces cytochromes P4501A1 (CYP1A1) and CYP1A2, as well as phase 2 pathways, leading to enhanced metabolism and excretion of IQ. However, the chemopreventive activity is dependent on the dose of I3C, and at low doses which do not induce CYP1A activity, there is evidence for increased IQ-DNA adduct formation in vivo. The present study examined the fate of IQ in the rat and the profile of urinary metabolites across a broad range of I3C doses. Male F344 rats were given a single injection of I3C by oral gavage, at a dose equivalent to that received from a single daily exposure to 0, 5, 10, 25, 50, 100, 200, 500 or 1000 ppm I3C in the diet, or they were given the 1000-ppm-equivalent dose of I3C for 14 consecutive days. Subsequently, each rat was given C-14-labeled IQ (5 mg/kg; 0.1 mCi/kg) and the animal was sacrificed 8 It later. With increasing I3C, there was a dose-dependent decrease in IQ-associated radiolabel in several systemic tissues, and an increase in the radiolabel eliminated via the feces. In the urine, there was a dose-dependent increase in IQ-5-O-glucuronide and IQ-5-O-sulfate metabolites, and a concomitant decrease in the IQ-sulfamate at intermediate and high doses of I3C. However, 5- and 10 ppm-equivalent doses of I3C enhanced the levels of IQ-sulfamate compared with controls, possibly due to the high ratio of hepatic CYP1A2 versus CYP1A1 activities at these I3C doses. The possible significance of the low versus high dose effects are discussed in the context of ongoing clinical trials with I3C and the reported chemopreventive mechanisms in vivo. (C) 2003 Elsevier Science Ltd. All rights reserved.
引用
收藏
页码:1185 / 1192
页数:8
相关论文
共 64 条
[1]
AROMATIC HYDROCARBON RESPONSIVENESS-RECEPTOR AGONISTS GENERATED FROM INDOLE-3-CARBINOL INVITRO AND INVIVO - COMPARISONS WITH 2,3,7,8-TETRACHLORODIBENZO-PARA-DIOXIN [J].
BJELDANES, LF ;
KIM, JY ;
GROSE, KR ;
BARTHOLOMEW, JC ;
BRADFIELD, CA .
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA, 1991, 88 (21) :9543-9547
[2]
β-catenin mutation in rat colon tumors initiated by 1,2-dimethylhydrazine and 2-amino-3-methylimidazo[4,5-f]quinoline, and the effect of post-initiation treatment with chlorophyllin and indole-3-carbinol [J].
Blum, CA ;
Xu, MR ;
Orner, GA ;
Fong, AT ;
Bailey, GS ;
Stoner, GD ;
Horio, DT ;
Dashwood, RH .
CARCINOGENESIS, 2001, 22 (02) :315-320
[3]
Bonnesen C, 2001, CANCER RES, V61, P6120
[4]
Bradlow HI, 1996, J ENDOCRINOL, V150, pS259
[5]
BRADLOW HL, 1994, CANCER EPIDEM BIOMAR, V3, P591
[6]
EFFECTS OF DIETARY INDOLE-3-CARBINOL ON ESTRADIOL METABOLISM AND SPONTANEOUS MAMMARY-TUMORS IN MICE [J].
BRADLOW, HL ;
MICHNOVICZ, JJ ;
TELANG, NT ;
OSBORNE, MP .
CARCINOGENESIS, 1991, 12 (09) :1571-1574
[7]
Indole-3-carbinol and diindolylmethane as aryl hydrocarbon (Ah) receptor agonists and antagonists in T47D human breast cancer cells [J].
Chen, I ;
Safe, S ;
Bjeldanes, L .
BIOCHEMICAL PHARMACOLOGY, 1996, 51 (08) :1069-1076
[8]
Christensen JG, 1996, CANCER RES, V56, P574
[9]
Indole-3-carbinol inhibits the expression of cyclin-dependent kinase-6 and induces a G1 cell cycle arrest of human breast cancer cells independent of estrogen receptor signaling [J].
Cover, CM ;
Hsieh, SJ ;
Tran, SH ;
Hallden, G ;
Kim, GS ;
Bjeldanes, LF ;
Firestone, GL .
JOURNAL OF BIOLOGICAL CHEMISTRY, 1998, 273 (07) :3838-3847
[10]
Cover CM, 1999, CANCER RES, V59, P1244